|
|
12/12/23
|
Rani Therapeutics LLC, the operating subsidiary of Rani Therapeutics Holdings Inc, has signed a lease expansion for 33.3k sf of manufacturing, R&D and administrative space in Fremont. Rani is a Silicon Valley-based, clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs.
Rani’s new Fremont facility is located at 47709 Fremont Blvd in the Bayside Commons technology park. The property is owned by BKM Capital Partners. The biotherapeutics company is expanding its existing footprint in the region from 34k sf in two nearby locations in North San Jose and Milpitas, which it will also continue to occupy.
Cushman & Wakefield’s Alex Lagemann, Brandon Bain and Erik Hallgrimson represented Rani in its recent lease expansion. Terms of the deal were not disclosed. According to Lagemann, Rani’s new Fremont facility offers a convenient, strategic location along the I-880 Corridor close to its other existing facilities.
|
|
Return to the Archive page
|
|
|
|
|
|